Showing results (1651-1660 of 1,870) with videos related to

Sort By:
Pageof 187
Communications Biology|January 19, 2026
SH3 domains selectively activate the PI3 kinase through non-conventional tertiary contactsSafia S Aljedani, Anandsukeerthi Sandholu, Abdullah Aldehaiman, et al.
Frontiers in Neurology|December 10, 2021
Endovascular Biopsy of Vertebrobasilar Aneurysm in Patient With Polyarteritis NodosaKazim H Narsinh, Kamileh Narsinh, David B McCoy, et al.
European Heart Journal|September 11, 2019
Causal association between periodontitis and hypertension: evidence from Mendelian randomization and a randomized controlled trial of non-surgical periodontal therapyMarta Czesnikiewicz-Guzik, Grzegorz Osmenda, Mateusz Siedlinski, et al.
JCO Precision Oncology|January 27, 2025
Clinical Activity of Mitogen-Activated Protein Kinase Inhibitors in Patients With MAP2K1 (MEK1)-Mutated Metastatic CancersMatthew Dankner, Emmanuelle Rousselle, Sarah Petrecca, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Pathological microcircuits and epileptiform events in patient hippocampal slicesMatthew A T Elliott, John P Andrews, Tjitse van der Molen, et al.
Vascular Medicine (London, England)|May 10, 2022
Artificial intelligence for the evaluation of peripheral artery disease using arterial Doppler waveforms to predict abnormal ankle-brachial indexRobert D McBane, Dennis H Murphree, David Liedl, et al.
American Journal of Hematology|June 17, 2022
Clinical characteristics, prognostic indicators, and survival outcomes in intravascular lymphoma: Mayo Clinic experience (2003-2018)Karan Seegobin, Zhuo Li, Muhamad Alhaj Moustafa, et al.
Blood Advances|July 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCLArushi Khurana, Raphael Mwangi, Loretta J Nastoupil, et al.
Blood|February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institutionSaad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
Blood|April 30, 2015
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphomaThomas E Witzig, Craig Reeder, Jing Jing Han, et al.
Pageof 187